Loading
Life sciences · Interventional Study
ClinicalTrials.gov · October 6, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Interventional Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT05823090). This is a study registration, not published results. Lead sponsor: Ann & Robert H Lurie Children's Hospital of Chicago. Recruitment status: COMPLETED. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 9 participants (ACTUAL). Conditions: Depression, Adolescent - Emotional Problem. Interventions: DEVICE: light box (Carex DayLight Classic Model). Primary outcome measures: Depression Severity , Baseline to week 2, week 8; Adherence to BLT in Adolescent Outpatients With Depression , 8 week study period (measured at Week 2, Week 4, and Week 8). Brief summary: The goal of this placebo lead-in clinical trial was to test bright light therapy (BLT) in adolescents with depression. The main question\[s\] it aimed to answer were: 1. characterize and define facilitators/barriers to treatment with BLT in adolescents); 2. evaluate the acceptability and feasibility of outpatient BLT in a dose titration protocol; 3. establish an effective, safe and tolerable light dose.